Onco aims to enhance its ability to accelerate cancer detection, precision oncology research, and drug development. Inka Health has developed the proprietary SynoGraph™ platform, which merges ...
VANCOUVER, BC / ACCESSWIRE / January 8, 2025 / Onco-Innovations Limited (CSE ... and contingent upon U.S. Federal Drug Administration (FDA) Phase 1 - 3 clinical trials being completed and approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback